Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment. The Company’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccines, neuroscience, pediatrics, and rare and orphan diseases. Synteract has conducted nearly 4,000 studies on six continents in over 62 countries.
Location: United States, North Carolina, Morrisville
Employees: 501-1000
Founded date: 1995
Investors 1
| Date | Name | Website |
| - | Northstar ... | northstarc... |
Mentions in press and media 5
| Date | Title | Description |
| 14.09.2021 | Closing the Gap: Broadening Representation in Clinical Trials, Upcoming Webinar Hosted by Xtalks | Racial diversity in clinical trials enables the ability to conduct subgroup analyses based on drug metabolism and biomarker differences that will identify differences in biology, efficacy and tolerability between different racial groups of ... |
| 06.04.2021 | Forward-Focused Oncology: Applying Lessons Learned from COVID to Strengthen Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks | Participants will have a stronger strategy for tackling oncology studies that will keep their trials running in the post-pandemic environment. TORONTO (PRWEB) April 06, 2021 The COVID pandemic has had a tremendous impact on clinical develop... |
| 11.03.2021 | Natural History Data and the Path to Registration in Pediatric Rare Disease Research, Upcoming Webinar Hosted by Xtalks | As is true for all rare disease research, there are logistical challenges to gathering natural history data, and a clinical program may hinge on the existence and robustness of this dataset. TORONTO (PRWEB) March 11, 2021 As the clinical re... |
| 03.03.2021 | The Critical Impact of Rater Training in Dermatology Clinical Trials, Upcoming Webinar Hosted by Xtalks | Since ensuring rating accuracy and consistency are critical, rater training is an important step that has been proven to reduce rater errors. TORONTO (PRWEB) March 03, 2021 In clinical studies, accuracy and consistency are paramount. Howeve... |
| - | Wendel Barr Joins Synteract as Chief Executive Former Covance COO sees opportunity for growth at well-respected West coast CRO | Synteract, Inc., a full-service, global contract research organization (CRO) dedicated to meeting the clinical research needs of biotechnology, medical device, and pharmaceutical companies, today announced it has appointed Wendel Barr as th... |